FilingPulse

MIRA insider filings

MIRA PHARMACEUTICALS, INC. — 34 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-06-15. Screen MIRA transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for MIRA between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.

Recent insider filings — MIRA PHARMACEUTICALS, INC.

FiledFormInsiderReported transactionsSource
2026-06-154Whalen Matthew Pratt — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-06-154Shekhat Denil Nanji — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-06-154MacPherson Edward Clouston — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-06-154Del Giudice Matthew Paul — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-04-014Aminov Erez — Chief Executive Officer, DirectorGrant/award (A): 83,500 (derivative) @ $0EDGAR
2025-10-034Shekhat Denil Nanji — DirectorGrant/award (A): 22,378 @ $1.35EDGAR
2025-10-034Aminov Erez — Chief Executive Officer, DirectorGrant/award (A): 2,685,456EDGAR
2025-09-184Aminov Erez — Chief Executive Officer, DirectorGrant/award (A): 150,000 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0EDGAR
2025-09-034Aminov Erez — Chief Executive Officer, DirectorGrant/award (A): 62,500 @ $1.37EDGAR
2024-12-104Aminov Erez — Chief Executive Officer, DirectorGrant/award (A): 2,000,000 (derivative) @ $0 · Grant/award (A): 500,000 (derivative) @ $0EDGAR
2024-12-104Yanez Michelle — Chief Financial OfficerGrant/award (A): 150,000 (derivative) @ $0EDGAR
2024-12-104Whalen Matthew Pratt — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2024-12-104Shekhat Denil Nanji — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-12-104MacPherson Edward Clouston — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2024-12-104Del Giudice Matthew Paul — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2024-11-274Aminov Erez — Chief Executive Officer, DirectorSale (S): 55,410 @ $1.39 · Sale (S): 44,590 @ $1.27EDGAR
2024-08-304McNulty Brian Patrick — 10% owner
Bay Shore Trust — 10% owner		Sale (S): 200,000 @ $1.96EDGAR
2024-06-214Shekhat Denil Nanji — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-05-304Aminov Erez — Chief Executive Officer, DirectorGrant/award (A): 379,000 (derivative) @ $0EDGAR
2024-05-224Aminov Erez — Chief Executive Officer, DirectorPurchase (P): 2,000 @ $1 · Purchase (P): 1,000 @ $1.03 · Purchase (P): 500 @ $1.02 · Purchase (P): 2,000 @ $0.84 · Purchase (P): 1,000 @ $0.85 · Purchase (P): 600 @ $0.87 · +2 moreEDGAR
2024-03-274Yanez Michelle — Chief Financial OfficerGrant/award (A): 150,000 (derivative) @ $0EDGAR
2024-03-274Aminov Erez — Chief Executive Officer, DirectorGrant/award (A): 300,000 (derivative) @ $0EDGAR
2024-03-274Shekhat Denil Nanji — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-03-274Jerman Michael Allen — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-03-274Del Giudice Matthew Paul — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-03-274MacPherson Edward Clouston — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2023-12-274McNulty Brian Patrick — 10% owner
Bay Shore Trust — 10% owner		Sale (S): 13,367 @ $5.07 · Sale (S): 2,500 @ $5 · Sale (S): 3,213 @ $4.00 · Sale (S): 121 @ $4 · Sale (S): 3,699 @ $3.98 · Sale (S): 2,421 @ $3.77 · +16 moreEDGAR
2023-11-174Bay Shore Trust — 10% owner
McNulty Brian Patrick — 10% owner		Grant/award (A): 700,000 (derivative)EDGAR
2023-08-244Cappy George — 10% owner
Bay Shore Trust — 10% owner		Purchase (P): 119,048 @ $7EDGAR
2023-08-214Yanez Michelle — CFO, Secretary and TreasurerGrant/award (A): 20,000 (derivative) @ $0EDGAR
2023-08-214Nicholoudis Christos — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2023-08-214Aminov Erez — CEO and Director, DirectorGrant/award (A): 150,000 (derivative) @ $0EDGAR
2023-08-214Chapman Christopher C JR — Executive Chairman, DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2023-08-044Cappy George — 10% owner
Bay Shore Trust — 10% owner		Purchase (P): 157,170 @ $7EDGAR

Recent 8-K events — MIRA PHARMACEUTICALS, INC.

FiledFormItems reportedSource
2026-09-178-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-09-168-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits		EDGAR
2026-09-018-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-08-068-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-07-318-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-07-108-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-07-068-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-258-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-178-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-088-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits		EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=MIRA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →